Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.
Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL. Sci Rep. 2017 08 23; 7(1):9192.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Cell Movement
Cell Survival
Disease Models, Animal
Drug Resistance, Neoplasm
ErbB Receptors
Gene Expression
Gene Knockdown Techniques
Humans
Lung Neoplasms
Mice
Mutation
Neoplasm Metastasis
Phosphorylation
Protein Kinase Inhibitors
Proteolysis
Proto-Oncogene Proteins c-cbl
Proto-Oncogene Proteins c-met
RNA Interference
RNA, Small Interfering
Xenograft Model Antitumor Assays
authors with profiles
Ravi Salgia
Everett E. Vokes